Objectives: To evaluate a stepwise approach to chronic cough that emph
asized initial treatment of all patients with an antihistamine-deconge
stant for postnasal drip and to determine the value of routine broncho
provocation challenge in the evaluation of chronic cough. Design: Pros
pective trial using an algorithm for chronic cough in immunocompetent
nonsmoking outpatients. Setting: University-based pulmonary practice.
Patients: Forty-five patients met the inclusion criteria. The mean dur
ation of cough was 140 weeks (range, 3 to 2080 weeks), and the mean se
verity of cough as assessed by patients on a four-point scale was ''se
vere.'' Results: Marked improvement and resolution (mean, 3.1 and 7.1
weeks, respectively), with resolution in 96% of patients. Antihistamin
e-decongestant therapy was beneficial in 39 of 45 patients and was the
only therapy needed for 16 patients. Bronchoprovocation challenge had
a negative predictive value of 100% and a positive predictive value o
f 74% for cough caused by asthma. No significant relationship was foun
d between the time to cough resolution and duration or severity of cou
gh. Eighteen percent of patients experienced a recurrence of cough at
a follow-up interval of 3 months. Conclusions: A sequential approach t
o chronic cough that emphasizes initial treatment with an antihistamin
e-decongestant is effective. Bronchoprovocation challenge is useful in
evaluating patients with chronic cough but can be delayed until the i
nitial response to antihistamine-decongestant therapy has been assesse
d. The 18% incidence of recurrence highlights the fact that cough ofte
n is the manifestation of a chronic or recurring process that requires
chronic or episodic therapy.